A distinct metabolic signature predicts development of fasting plasma glucose

Table 1 Characterisation of the investigated MESY-BEPO sub-cohort

Clinical Characteristics	Baseline	Follow-up
Age [years]	55.7 ± 11.7	61.5 ± 11.5
Gender [% female]	62.2
Waist circumference [cm]	93.8 ± 13.8	94.6 ± 17.3
Body mass index [kg/m²]	28.6 ± 5.2	29.1 ± 5.3
Fasting glucose [mg]	92.1 ± 11.6	100.5 ± 13.6
Δglucose [mg/(dl · a)]	1.0 ± 2.3
Time between baseline and follow-up [years]	5.6 ± 0.7

Characterisation of the investigated MESY-BEPO sub-cohort (n = 172) at baseline and follow-up. Data are presented as mean ± standard deviation.